Search

for
Search:

GlossaryEstrogen Receptor-Positive Breast Cancer

cancer type where cells grow due to estrogen binding

Estrogen Receptor-Positive Breast Cancer (ER+ Breast Cancer) is a type of breast cancer where the cancer cells have receptors that bind to the hormone estrogen. This binding promotes the growth of the cancer cells. Treatments often involve hormone therapies that block estrogen from attaching to these receptors, thereby slowing or stopping the cancer's growth.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 1000+ results

research Aldosterone- and Cortisol-Cosecreting Adrenal Adenoma, Ovarian Hyperthecosis, and Breast Cancer

1 citations , September 2020 in “Endocrinology, Diabetes & Metabolism Case Reports”

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

research Activation of Breast Cancer Cell Proliferation by ROR-Alpha Through Aromatase Promoter

March 2010 in “Ejc Supplements”

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

research Revising the Role of the Androgen Receptor in Breast Cancer

68 citations , April 2014 in “Journal of Molecular Endocrinology”

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

research Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition

451 citations , March 2005 in “Endocrine Reviews”

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

research Abstract P5-09-21: Selective Androgen Receptor Modulators (SARMs): Enobosarm as Targeted Therapy for the Treatment of Androgen Receptor-Positive Breast Cancer

2 citations , December 2013 in “Cancer research”

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

View more "er-positive breast cancer" in research →

Community Join

5 / 121 results

community What an amazing time to be alive

in Finasteride/Dutasteride 187 upvotes 2 years ago

The post discusses a user's experience with hair loss treatments, specifically topical finasteride, minoxidil, and micro-needling, and their plan to switch to oral versions and add Dutasteride. The conversation includes various responses, with some users sharing their own experiences and side effects, and others expressing desire for a more permanent hair loss solution.

community Any finasteride users have a history of depression?

in Finasteride/Dutasteride 26 upvotes 1 year ago

The conversation discusses finasteride for hair loss, especially among those with a history of depression. Users shared mixed experiences, with some reporting no issues and others experiencing worsened depression.

community Progress Pictures 10.2019 - present

in Progress Pictures 87 upvotes 1 year ago

The conversation discusses hair loss treatments, including finasteride, topical and oral minoxidil, and the potential use of dutasteride. The user shares progress and seeks advice on whether to start dutasteride, noting positive results with current treatments but concerns about long-term effects.

community The Placebo Group Has It Worse Than The Standard Prescription 0.5mg Group. -The fear is all in your head.

in Finasteride/Dutasteride 187 upvotes 5 months ago

Dutasteride at 0.5mg may have fewer sexual side effects than expected, with many side effects attributed to psychological factors (nocebo effect). The placebo group experienced more side effects, suggesting fear and anxiety might contribute to perceived side effects.

community 5 Months on topical Fin/Min progress: grows hair and boobs

in Progress Pictures 159 upvotes 5 months ago

The user experienced significant hair growth using topical finasteride and minoxidil but noticed nipple changes, suggesting early gynecomastia. They plan to stop the treatment and consider blood work to check hormonal balance.

View more "er-positive breast cancer" in community →